Category: BioTech

Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

China Telecom Reaps Efficiency Gains in 1Q After 3G Assets Acquisition

Carrier China Telecom CHA increased first-quarter revenue 15% year over year to CNY 78 billion ($12.6 billion) thanks to strong mobile service revenue and handset sales. EBITDA grew at a much faster pace of 36%, as the firm benefited from scale efficiencies on its 3G network after it acquired the assets from its parent at the end of December. We are maintaining our narrow economic … Continue reading China Telecom Reaps Efficiency Gains in 1Q After 3G Assets Acquisition

John MeadyLeave a comment
BioTech, Finance

Biotech Stocks Weekly Roundup

PRevious Few Days have been very eventful for the Biotech Stocks. Last week, earnings remained in focus with several companies reporting their second quarter results. While Amgen’s (AMGN) results remained impressive, Vertex (VRTX) posted a wider loss. Meanwhile, Regeneron (REGN) missed earnings expectations by a pretty wide margin though Eylea sales continued to impress. Among all this, the Ebola outbreak is also making headlines and … Continue reading Biotech Stocks Weekly Roundup

Richard Atkins
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, software, Software, Tech IPO

Investments in Mobile Weighed on First-Quarter Margins for Baidu; Shares Undervalued

Chinese search engine Baidu BIDU posted a 40% increase in first-quarter revenue that met our expectations, although margins came under pressure due to aggressive investments in mobile Internet. We believe these strategic investments behind product innovation, engineering talents, network infrastructure, and marketing campaigns are critical to fortifying Baidu’s competitiveness in the fastgrowing mobile Internet space over the longer term. We applaud management’s decision to accelerate … Continue reading Investments in Mobile Weighed on First-Quarter Margins for Baidu; Shares Undervalued

John MeadyLeave a comment
BioTech, Finance

Biotech Stock Update: Regeneron Misses on Earnings in Q2

Regeneron Pharmaceuticals’ (REGN) second quarter 2014 adjusted earnings (including stock-based compensation expense) of $1.89 per share were well short of the Consensus Estimate of $2.33. The company had earned $1.36 per share in the year-ago quarter. Results were impacted by higher costs. Including one-time items, earnings increased 3.8% to 82 cents per share. A higher tax rate affected results. Excluding stock based compensation expenses the … Continue reading Biotech Stock Update: Regeneron Misses on Earnings in Q2

Richard Atkins
FB Nasdaq FB Facebook
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Avon Takes Steps to Enhance its Corporate Governance; Shares Far From a Beauty

Avon Products AVP announced on Friday that independent chairman Fred Hassan would be stepping down immediately in light of ” his other professional commitments” (which presently include working as a managing director and partner at private-equity firm Warburg Pincus, as well as a director at Time Warner TWX and chairman of Bausch and Lomb) . Former Campbell Soup CPB CEO Doug Conant (a director since … Continue reading Avon Takes Steps to Enhance its Corporate Governance; Shares Far From a Beauty

John MeadyLeave a comment
BioTech, Finance

Biotech Stock in Spotlight: As the World Awaits Ebola Treatment, Tekmira Pharma In Prime Focus

The outbreak of the deadly and highly infectious Ebola disease in Africa has already claimed multiple lives. According to media reports many health workers including doctors and nurses have also fallen a prey to the worst outbreak of the disease. According to the World Health Organization (WHO), the disease first surfaced in 1976. Among other places, it affected the Yambuku village situated close to the … Continue reading Biotech Stock in Spotlight: As the World Awaits Ebola Treatment, Tekmira Pharma In Prime Focus

Richard Atkins